(+)-schisandrin B multiple interactions ISO RGD:67396 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CEACAM1 mRNA] CTD PMID:31150632 (-)-demecolcine increases expression ISO RGD:10241 6480464 Demecolcine results in increased expression of CEACAM1 mRNA CTD PMID:23649840 (S)-nicotine increases expression EXP 6480464 Nicotine results in increased expression of CEACAM1 mRNA CTD PMID:17997037 17alpha-ethynylestradiol increases expression ISO RGD:67396 6480464 Ethinyl Estradiol results in increased expression of CEACAM1 mRNA CTD PMID:12075121 more ... 17beta-estradiol increases expression ISO RGD:10241 6480464 Estradiol results in increased expression of CEACAM1 mRNA CTD PMID:19619570 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of CEACAM1 mRNA CTD PMID:15598610 17beta-estradiol multiple interactions ISO RGD:10241 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of CEACAM1 mRNA CTD PMID:19619570 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of CEACAM1 mRNA CTD PMID:15289156 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:10241 6480464 Tetrachlorodibenzodioxin results in decreased expression of CEACAM1 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:10241 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of CEACAM1 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:10241 6480464 Tetrachlorodibenzodioxin results in increased expression of CEACAM1 mRNA CTD PMID:23152189 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CEACAM1 mRNA CTD PMID:19770486 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:67396 6480464 Tetrachlorodibenzodioxin results in increased expression of CEACAM1 mRNA CTD PMID:16054898 , PMID:18796159 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:67396 6480464 Tetrachlorodibenzodioxin results in decreased expression of CEACAM1 mRNA CTD PMID:20959002 , PMID:23238561 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CEACAM1 mRNA CTD PMID:23238561 3,4-dichloroaniline increases expression ISO RGD:10241 6480464 3, 4-dichloroaniline results in increased expression of CEACAM1 mRNA CTD PMID:24172598 3,4-methylenedioxymethamphetamine decreases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of CEACAM1 mRNA CTD PMID:26251327 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of CEACAM1 mRNA CTD PMID:18648102 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of CEACAM1 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine affects expression ISO RGD:10241 6480464 Decitabine affects the expression of CEACAM1 mRNA CTD PMID:23300844 acrylamide decreases expression ISO RGD:67396 6480464 Acrylamide results in decreased expression of CEACAM1 mRNA CTD PMID:28959563 aflatoxin B1 affects expression ISO RGD:10241 6480464 Aflatoxin B1 affects the expression of CEACAM1 protein CTD PMID:20106945 aflatoxin B1 increases expression ISO RGD:10241 6480464 Aflatoxin B1 results in increased expression of CEACAM1 mRNA CTD PMID:21641981 , PMID:22100608 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of CEACAM1 mRNA CTD PMID:19770486 aldehydo-D-glucose multiple interactions ISO RGD:10241 6480464 cobaltiprotoporphyrin inhibits the reaction [Glucose results in decreased expression of CEACAM1 mRNA], cobaltiprotoporphyrin inhibits the reaction [Glucose results in decreased secretion of CEACAM1 protein] CTD PMID:19924377 aldehydo-D-glucose decreases expression ISO RGD:10241 6480464 Glucose results in decreased expression of CEACAM1 mRNA CTD PMID:19924377 aldehydo-D-glucose decreases secretion ISO RGD:10241 6480464 Glucose results in decreased secretion of CEACAM1 protein CTD PMID:19924377 all-trans-retinoic acid increases expression ISO RGD:10241 6480464 Tretinoin results in increased expression of CEACAM1 mRNA CTD PMID:23830798 ammonium chloride affects expression ISO RGD:67396 6480464 Ammonium Chloride affects the expression of CEACAM1 mRNA CTD PMID:16483693 antirheumatic drug decreases expression ISO RGD:10241 6480464 Antirheumatic Agents results in decreased expression of CEACAM1 mRNA CTD PMID:24449571 Azaspiracid increases expression ISO RGD:10241 6480464 azaspiracid results in increased expression of CEACAM1 mRNA CTD PMID:21853993 , PMID:28939011 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of CEACAM1 mRNA CTD PMID:19770486 benzo[a]pyrene increases expression ISO RGD:67396 6480464 Benzo(a)pyrene results in increased expression of CEACAM5 protein CTD PMID:21467743 benzo[a]pyrene increases expression ISO RGD:10241 6480464 Benzo(a)pyrene results in increased expression of CEACAM1 mRNA CTD PMID:21632981 , PMID:26238291 benzo[a]pyrene diol epoxide I increases expression ISO RGD:10241 6480464 7 more ... CTD PMID:26238291 beta-naphthoflavone multiple interactions ISO RGD:67396 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CEACAM1 mRNA CTD PMID:18164116 bis(2-chloroethyl) sulfide increases expression ISO RGD:10241 6480464 Mustard Gas results in increased expression of CEACAM1 mRNA CTD PMID:25102026 bisphenol A increases expression ISO RGD:67396 6480464 bisphenol A results in increased expression of CEACAM1 mRNA CTD PMID:12075121 bisphenol A decreases expression ISO RGD:67396 6480464 bisphenol A results in decreased expression of CEACAM1 mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:10241 6480464 bisphenol A results in increased expression of CEACAM1 mRNA CTD PMID:22576693 bisphenol F increases expression EXP 6480464 bisphenol F results in increased expression of CEACAM1 mRNA CTD PMID:30951980 buspirone decreases expression ISO RGD:67396 6480464 Buspirone results in decreased expression of CEACAM1 mRNA CTD PMID:24136188 butanal decreases expression ISO RGD:10241 6480464 butyraldehyde results in decreased expression of CEACAM1 mRNA CTD PMID:26079696 calciol increases expression EXP 6480464 Cholecalciferol results in increased expression of CEACAM1 mRNA CTD PMID:17170073 calcitriol increases expression ISO RGD:10241 6480464 Calcitriol results in increased expression of CEACAM1 mRNA CTD PMID:26485663 camptothecin increases expression ISO RGD:10241 6480464 Camptothecin results in increased expression of CEACAM1 mRNA CTD PMID:17374387 chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of CEACAM1 mRNA CTD PMID:23125180 chromium(6+) affects expression EXP 6480464 chromium hexavalent ion affects the expression of CEACAM1 mRNA CTD PMID:28472532 cisplatin multiple interactions ISO RGD:10241 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of CEACAM1 mRNA, [Cisplatin co-treated with Paclitaxel] results in increased expression of CEACAM1 mRNA CTD PMID:20705681 , PMID:27392435 cisplatin increases expression ISO RGD:10241 6480464 Cisplatin results in increased expression of CEACAM1 mRNA CTD PMID:27392435 cisplatin affects expression ISO RGD:10241 6480464 Cisplatin affects the expression of CEACAM1 mRNA CTD PMID:23300844 clofibrate decreases expression EXP 6480464 Clofibrate results in decreased expression of CEACAM1 mRNA CTD PMID:17585979 clofibrate multiple interactions EXP 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of CEACAM1 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CEACAM1 mRNA] CTD PMID:17585979 clofibric acid affects expression ISO RGD:67396 6480464 Clofibric Acid affects the expression of CEACAM1 mRNA CTD PMID:17602206 crocidolite asbestos increases expression ISO RGD:10241 6480464 Asbestos, Crocidolite results in increased expression of CEACAM1 mRNA CTD PMID:25351596 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of CEACAM1 mRNA CTD PMID:19770486 cyclosporin A decreases expression ISO RGD:10241 6480464 Cyclosporine results in decreased expression of CEACAM1 mRNA CTD PMID:20106945 , PMID:25562108 D-glucose decreases expression ISO RGD:10241 6480464 Glucose results in decreased expression of CEACAM1 mRNA CTD PMID:19924377 D-glucose multiple interactions ISO RGD:10241 6480464 cobaltiprotoporphyrin inhibits the reaction [Glucose results in decreased expression of CEACAM1 mRNA], cobaltiprotoporphyrin inhibits the reaction [Glucose results in decreased secretion of CEACAM1 protein] CTD PMID:19924377 D-glucose decreases secretion ISO RGD:10241 6480464 Glucose results in decreased secretion of CEACAM1 protein CTD PMID:19924377 daunorubicin increases expression ISO RGD:10241 6480464 Daunorubicin results in increased expression of CEACAM1 mRNA CTD PMID:17374387 decabromodiphenyl ether increases expression ISO RGD:67396 6480464 decabromobiphenyl ether results in increased expression of CEACAM1 mRNA CTD PMID:23914054 dexamethasone increases expression ISO RGD:67396 6480464 Dexamethasone results in increased expression of CEACAM1 mRNA CTD PMID:17522070 dicrotophos increases expression ISO RGD:10241 6480464 dicrotophos results in increased expression of CEACAM1 mRNA CTD PMID:28302478 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of CEACAM1 mRNA CTD PMID:15289156 Dinophysistoxin 1 increases expression ISO RGD:10241 6480464 dinophysistoxin 1 results in increased expression of CEACAM1 mRNA CTD PMID:21853993 , PMID:28939011 diuron increases expression ISO RGD:10241 6480464 Diuron metabolite results in increased expression of CEACAM1 mRNA CTD PMID:24172598 doramapimod decreases expression ISO RGD:67396 6480464 BIRB 796 results in decreased expression of CEACAM1 mRNA CTD PMID:24303162 entinostat increases expression ISO RGD:10241 6480464 entinostat results in increased expression of CEACAM1 mRNA CTD PMID:27188386 erythromycin estolate decreases expression ISO RGD:67396 6480464 Erythromycin Estolate results in decreased expression of CEACAM1 mRNA CTD PMID:17522070 ethyl methanesulfonate increases expression ISO RGD:10241 6480464 Ethyl Methanesulfonate results in increased expression of CEACAM1 mRNA CTD PMID:23649840 etoposide increases expression ISO RGD:10241 6480464 Etoposide results in increased expression of CEACAM1 mRNA CTD PMID:17374387 flurbiprofen increases expression EXP 6480464 Flurbiprofen results in increased expression of CEACAM1 mRNA CTD PMID:16949054 flutamide decreases expression ISO RGD:67396 6480464 Flutamide results in decreased expression of CEACAM1 mRNA CTD PMID:24793618 folic acid multiple interactions ISO RGD:10241 6480464 [Folic Acid deficiency co-treated with Methotrexate] results in increased expression of CEACAM1 mRNA CTD PMID:24657277 formaldehyde increases expression ISO RGD:10241 6480464 Formaldehyde results in increased expression of CEACAM1 mRNA CTD PMID:23649840 formaldehyde decreases expression ISO RGD:10241 6480464 Formaldehyde results in decreased expression of CEACAM1 mRNA CTD PMID:28937961 fumonisin B1 decreases expression EXP 6480464 fumonisin B1 results in decreased expression of CEACAM1 mRNA CTD PMID:16221962 genistein increases expression ISO RGD:67396 6480464 Genistein results in increased expression of CEACAM1 mRNA CTD PMID:12075121 genistein increases expression EXP 6480464 Genistein results in increased expression of CEACAM1 mRNA CTD PMID:15289156 glafenine decreases expression ISO RGD:67396 6480464 Glafenine results in decreased expression of CEACAM1 mRNA CTD PMID:24136188 glucose decreases expression ISO RGD:10241 6480464 Glucose results in decreased expression of CEACAM1 mRNA CTD PMID:19924377 glucose multiple interactions ISO RGD:10241 6480464 cobaltiprotoporphyrin inhibits the reaction [Glucose results in decreased expression of CEACAM1 mRNA], cobaltiprotoporphyrin inhibits the reaction [Glucose results in decreased secretion of CEACAM1 protein] CTD PMID:19924377 glucose decreases secretion ISO RGD:10241 6480464 Glucose results in decreased secretion of CEACAM1 protein CTD PMID:19924377 hydrazines decreases expression EXP 6480464 Hydrazines results in decreased expression of CEACAM1 mRNA CTD PMID:21647536 hydrogen peroxide affects expression ISO RGD:10241 6480464 Hydrogen Peroxide affects the expression of CEACAM1 mRNA CTD PMID:20044591 hydroquinone O-beta-D-glucopyranoside decreases expression ISO RGD:10241 6480464 Arbutin results in decreased expression of CEACAM1 mRNA CTD PMID:17103032 ibuprofen affects expression ISO RGD:10241 6480464 Ibuprofen affects the expression of CEACAM1 mRNA CTD PMID:17070997 isotretinoin decreases expression ISO RGD:10241 6480464 Isotretinoin results in decreased expression of CEACAM1 mRNA CTD PMID:20436886 kainic acid increases expression EXP 6480464 Kainic Acid results in increased expression of CEACAM1 mRNA CTD PMID:17997037 kojic acid decreases expression ISO RGD:10241 6480464 kojic acid results in decreased expression of CEACAM1 mRNA CTD PMID:16595896 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of CEACAM1 mRNA CTD PMID:22609695 lead diacetate increases methylation ISO RGD:67396 6480464 lead acetate results in increased methylation of CEACAM1 gene CTD PMID:29571894 lead diacetate decreases expression ISO RGD:67396 6480464 lead acetate results in decreased expression of CEACAM1 mRNA CTD PMID:22641619 leflunomide increases expression ISO RGD:10241 6480464 leflunomide results in increased expression of CEACAM1 mRNA CTD PMID:28988120 leflunomide increases expression ISO RGD:67396 6480464 leflunomide results in increased expression of CEACAM1 mRNA CTD PMID:24136188 methapyrilene decreases expression ISO RGD:67396 6480464 Methapyrilene results in decreased expression of CEACAM1 mRNA CTD PMID:30467583 methotrexate multiple interactions ISO RGD:10241 6480464 [Folic Acid deficiency co-treated with Methotrexate] results in increased expression of CEACAM1 mRNA CTD PMID:24657277 methyl methanesulfonate increases expression ISO RGD:10241 6480464 Methyl Methanesulfonate results in increased expression of CEACAM1 mRNA CTD PMID:23649840 N-nitrosodiethylamine multiple interactions ISO RGD:67396 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CEACAM1 mRNA CTD PMID:18164116 nefazodone decreases expression ISO RGD:67396 6480464 nefazodone results in decreased expression of CEACAM1 mRNA CTD PMID:24136188 nicotine increases expression EXP 6480464 Nicotine results in increased expression of CEACAM1 mRNA CTD PMID:17997037 nimesulide decreases expression ISO RGD:67396 6480464 nimesulide results in decreased expression of CEACAM1 mRNA CTD PMID:24136188 oxaliplatin multiple interactions ISO RGD:67396 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of CEACAM1 mRNA CTD PMID:25729387 ozone increases expression ISO RGD:67396 6480464 Ozone results in increased expression of CEACAM1 mRNA CTD PMID:16330353 ozone increases expression EXP 6480464 Ozone results in increased expression of CEACAM1 mRNA CTD PMID:19555225 p-toluidine decreases expression ISO RGD:67396 6480464 4-toluidine results in decreased expression of CEACAM1 mRNA CTD PMID:27638505 paclitaxel multiple interactions ISO RGD:10241 6480464 [Cisplatin co-treated with Paclitaxel] results in increased expression of CEACAM1 mRNA CTD PMID:20705681 paracetamol decreases expression ISO RGD:10241 6480464 Acetaminophen results in decreased expression of CEACAM1 mRNA CTD PMID:21420995 , PMID:29067470 paracetamol multiple interactions EXP 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of CEACAM1 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CEACAM1 mRNA] CTD PMID:17585979 paracetamol decreases expression ISO RGD:67396 6480464 Acetaminophen results in decreased expression of CEACAM1 mRNA CTD PMID:17522070 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of CEACAM1 mRNA CTD PMID:23091169 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of CEACAM1 mRNA CTD PMID:19270015 , PMID:25270620 pirinixic acid multiple interactions EXP 6480464 PPARA protein promotes the reaction [pirinixic acid results in decreased expression of CEACAM1 mRNA] CTD PMID:20059764 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of CEACAM1 mRNA CTD PMID:16221962 more ... progesterone increases expression ISO RGD:10241 6480464 Progesterone results in increased expression of CEACAM1 mRNA CTD PMID:18692832 propiconazole decreases expression EXP 6480464 propiconazole results in decreased expression of CEACAM1 mRNA CTD PMID:21278054 quinidine increases expression ISO RGD:67396 6480464 Quinidine results in increased expression of CEACAM1 mRNA CTD PMID:17522070 resveratrol increases expression ISO RGD:10241 6480464 resveratrol results in increased expression of CEACAM1 mRNA CTD PMID:15280659 , PMID:25888808 rofecoxib affects expression ISO RGD:10241 6480464 rofecoxib affects the expression of CEACAM1 mRNA CTD PMID:17070997 silicon dioxide decreases expression ISO RGD:10241 6480464 Silicon Dioxide analog results in decreased expression of CEACAM1 mRNA CTD PMID:25895662 silicon dioxide increases expression ISO RGD:10241 6480464 Silicon Dioxide results in increased expression of CEACAM1 mRNA CTD PMID:22300531 sodium arsenate increases expression EXP 6480464 sodium arsenate results in increased expression of CEACAM1 mRNA CTD PMID:21795629 testosterone decreases expression EXP 6480464 Testosterone results in decreased expression of CEACAM1 mRNA CTD PMID:20600201 , PMID:21669218 tetrachloromethane decreases expression ISO RGD:67396 6480464 Carbon Tetrachloride results in decreased expression of CEACAM1 mRNA CTD PMID:17522070 , PMID:31150632 tetrachloromethane multiple interactions EXP 6480464 [PANX1 protein co-treated with Carbon Tetrachloride] affects the expression of CEACAM1 mRNA CTD PMID:29987408 tetrachloromethane multiple interactions ISO RGD:67396 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CEACAM1 mRNA] CTD PMID:31150632 theophylline decreases expression ISO RGD:67396 6480464 Theophylline results in decreased expression of CEACAM1 mRNA CTD PMID:17522070 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of CEACAM1 mRNA CTD PMID:23557971 topotecan multiple interactions ISO RGD:67396 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of CEACAM1 mRNA CTD PMID:25729387 topotecan increases expression ISO RGD:67396 6480464 Topotecan results in increased expression of CEACAM1 mRNA CTD PMID:25729387 trichostatin A increases expression ISO RGD:10241 6480464 trichostatin A results in increased expression of CEACAM1 mRNA CTD PMID:24935251 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of CEACAM1 mRNA CTD PMID:28973697 tungsten decreases expression EXP 6480464 Tungsten results in decreased expression of CEACAM1 mRNA CTD PMID:30912803 valproic acid decreases methylation ISO RGD:10241 6480464 Valproic Acid results in decreased methylation of CEACAM1 gene CTD PMID:29154799 valproic acid increases expression ISO RGD:10241 6480464 Valproic Acid results in increased expression of CEACAM1 mRNA CTD PMID:23527032 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of CEACAM1 mRNA CTD PMID:17292431 vancomycin increases expression EXP 6480464 Vancomycin results in increased expression of CEACAM1 mRNA CTD PMID:18930951 vincristine increases expression ISO RGD:10241 6480464 Vincristine results in increased expression of CEACAM1 mRNA CTD PMID:23649840 zinc atom increases expression ISO RGD:67396 6480464 Zinc deficiency results in increased expression of CEACAM1 mRNA CTD PMID:11717422 zinc(0) increases expression ISO RGD:67396 6480464 Zinc deficiency results in increased expression of CEACAM1 mRNA CTD PMID:11717422
Biological Process blood vessel development IMP 2290270 (MGI:MGI:5317069, PMID:21081647) UniProtKB MGI:MGI:5317069 , PMID:21081647 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules IDA 2290270 (MGI:MGI:59357, PMID:1985902) MGI MGI:MGI:59357 , PMID:1985902 calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules IDA 2290270 (MGI:MGI:5608586, PMID:1633107) MGI MGI:MGI:5608586 , PMID:1633107 cell-cell junction organization IMP 2290270 (MGI:MGI:5525176, PMID:23800882) UniProtKB MGI:MGI:5525176 , PMID:23800882 common myeloid progenitor cell proliferation IMP 2290270 (MGI:MGI:4837548, PMID:21029969) UniProtKB MGI:MGI:4837548 , PMID:21029969 granulocyte colony-stimulating factor signaling pathway IMP 2290270 (MGI:MGI:4837548, PMID:21029969) UniProtKB MGI:MGI:4837548 , PMID:21029969 homophilic cell adhesion via plasma membrane adhesion molecules IDA 2290270 (MGI:MGI:5503958, PMID:10491101) MGI MGI:MGI:5503958 , PMID:10491101 insulin catabolic process IMP 2290270 (MGI:MGI:3819735, PMID:18544705) UniProtKB MGI:MGI:3819735 , PMID:18544705 negative regulation by host of viral genome replication IMP MGI:MGI:3053078 2290270 (MGI:MGI:55926, PMID:6327825) MGI MGI:MGI:55926 , PMID:6327825 negative regulation by host of viral process IMP MGI:MGI:2180785 2290270 (MGI:MGI:2148352, PMID:11483763) MGI MGI:MGI:2148352 , PMID:11483763 negative regulation by host of viral process IMP MGI:MGI:3053078 2290270 (MGI:MGI:1098064, PMID:9343248) MGI MGI:MGI:1098064 , PMID:9343248 negative regulation by host of viral process IDA 2290270 (MGI:MGI:3848729, PMID:19358828) MGI MGI:MGI:3848729 , PMID:19358828 negative regulation of bone resorption IMP MGI:MGI:5560663 2290270 (MGI:MGI:5691608, PMID:25490771) MGI MGI:MGI:5691608 , PMID:25490771 negative regulation of cytokine production IMP 2290270 (MGI:MGI:3693042, PMID:17081782) MGI MGI:MGI:3693042 , PMID:17081782 negative regulation of granulocyte differentiation IMP 2290270 (MGI:MGI:4837548, PMID:21029969) UniProtKB MGI:MGI:4837548 , PMID:21029969 negative regulation of hepatocyte proliferation IMP 2290270 (MGI:MGI:3057041, PMID:15467833) UniProtKB MGI:MGI:3057041 , PMID:15467833 negative regulation of interleukin-1 production IMP 2290270 (MGI:MGI:5478702, PMID:22496641) UniProtKB MGI:MGI:5478702 , PMID:22496641 negative regulation of interleukin-2 production IMP 2290270 (MGI:MGI:3693042, PMID:17081782) MGI MGI:MGI:3693042 , PMID:17081782 negative regulation of interleukin-2 production IMP MGI:MGI:2448686 , MGI:MGI:3693674 2290270 (MGI:MGI:3693042, PMID:17081782) MGI MGI:MGI:3693042 , PMID:17081782 negative regulation of JNK cascade IMP 2290270 (MGI:MGI:3693042, PMID:17081782) MGI MGI:MGI:3693042 , PMID:17081782 negative regulation of lipid biosynthetic process IMP 2290270 (MGI:MGI:3819735, PMID:18544705) UniProtKB MGI:MGI:3819735 , PMID:18544705 negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target IMP 2290270 (MGI:MGI:5512785, PMID:23696226) UniProtKB MGI:MGI:5512785 , PMID:23696226 negative regulation of osteoclast differentiation IMP 2290270 (MGI:MGI:5691608, PMID:25490771) MGI MGI:MGI:5691608 , PMID:25490771 negative regulation of platelet aggregation IMP 2290270 (MGI:MGI:3835235, PMID:19008452) UniProtKB MGI:MGI:3835235 , PMID:19008452 negative regulation of protein kinase activity IMP 2290270 (MGI:MGI:5478702, PMID:22496641) UniProtKB MGI:MGI:5478702 , PMID:22496641 negative regulation of T cell proliferation IMP 2290270 (MGI:MGI:3693042, PMID:17081782) MGI MGI:MGI:3693042 , PMID:17081782 negative regulation of T cell proliferation IMP MGI:MGI:3695215 2290270 (MGI:MGI:3693042 more ... MGI MGI:MGI:3693042 more ... negative regulation of vascular permeability IMP 2290270 (MGI:MGI:5317069, PMID:21081647) UniProtKB MGI:MGI:5317069 , PMID:21081647 Peyer's patch development IMP MGI:MGI:5609428 2290270 (MGI:MGI:5451119, PMID:23123061) MGI MGI:MGI:5451119 , PMID:23123061 Peyer's patch development IMP MGI:MGI:3053071 , MGI:MGI:5609428 2290270 (MGI:MGI:5451119, PMID:23123061) MGI MGI:MGI:5451119 , PMID:23123061 positive regulation by host of viral process IMP MGI:MGI:2180785 2290270 (MGI:MGI:2148352, PMID:11483763) MGI MGI:MGI:2148352 , PMID:11483763 positive regulation by host of viral process IMP MGI:MGI:3027072 2290270 (MGI:MGI:1098064, PMID:9343248) MGI MGI:MGI:1098064 , PMID:9343248 positive regulation of activation-induced cell death of T cells IMP MGI:MGI:5609428 2290270 (MGI:MGI:5451119, PMID:23123061) MGI MGI:MGI:5451119 , PMID:23123061 positive regulation of calcineurin-NFAT signaling cascade IMP MGI:MGI:3053071 more ... 2290270 (MGI:MGI:5451119, PMID:23123061) MGI MGI:MGI:5451119 , PMID:23123061 positive regulation of CD4-positive, alpha-beta T cell activation IMP MGI:MGI:3053071 more ... 2290270 (MGI:MGI:5451119, PMID:23123061) MGI MGI:MGI:5451119 , PMID:23123061 positive regulation of CD4-positive, alpha-beta T cell proliferation IMP MGI:MGI:3053071 , MGI:MGI:5609428 2290270 (MGI:MGI:5451119, PMID:23123061) MGI MGI:MGI:5451119 , PMID:23123061 positive regulation of CD8-positive, alpha-beta T cell activation IMP MGI:MGI:3053071 more ... 2290270 (MGI:MGI:5451119, PMID:23123061) MGI MGI:MGI:5451119 , PMID:23123061 positive regulation of immunoglobulin secretion IMP MGI:MGI:3053071 more ... 2290270 (MGI:MGI:5451119, PMID:23123061) MGI MGI:MGI:5451119 , PMID:23123061 positive regulation of JNK cascade IDA 2290270 (MGI:MGI:2667426, PMID:12832451) MGI MGI:MGI:2667426 , PMID:12832451 positive regulation of MAP kinase activity ISO UniProtKB:P16573 2290270 (MGI:MGI:2179379, PMID:11994468) MGI MGI:MGI:2179379 , PMID:11994468 positive regulation of T cell proliferation IMP MGI:MGI:5609428 2290270 (MGI:MGI:5451119, PMID:23123061) MGI MGI:MGI:5451119 , PMID:23123061 positive regulation of vasculogenesis IMP 2290270 (MGI:MGI:5559845, PMID:22962327) UniProtKB MGI:MGI:5559845 , PMID:22962327 regulation of blood vessel remodeling IMP 2290270 (MGI:MGI:3640069, PMID:16680193) UniProtKB MGI:MGI:3640069 , PMID:16680193 regulation of endothelial cell differentiation IDA 2290270 (MGI:MGI:3640069, PMID:16680193) UniProtKB MGI:MGI:3640069 , PMID:16680193 regulation of endothelial cell migration IDA 2290270 (MGI:MGI:3640069, PMID:16680193) UniProtKB MGI:MGI:3640069 , PMID:16680193 regulation of epidermal growth factor receptor signaling pathway IMP 2290270 (MGI:MGI:3057041, PMID:15467833) UniProtKB MGI:MGI:3057041 , PMID:15467833 regulation of sprouting angiogenesis IMP 2290270 (MGI:MGI:3640069, PMID:16680193) UniProtKB MGI:MGI:3640069 , PMID:16680193 viral entry into host cell IDA 2290270 (MGI:MGI:49235, PMID:1719235) MGI MGI:MGI:49235 , PMID:1719235 viral process IEA UniProtKB-KW:KW-0945 2290270 UniProtKB GO_REF:0000004, MGI:MGI:1354194 Cellular Component adherens junction ISO RGD:67396 2290270 RGD GO_REF:0000096, MGI:MGI:4417868 apical plasma membrane ISO RGD:67396 2290270 RGD GO_REF:0000096, MGI:MGI:4417868 apical plasma membrane ISO UniProtKB:P13688 2290270 MGI GO_REF:0000096, MGI:MGI:4834177 basal plasma membrane ISO RGD:67396 2290270 RGD GO_REF:0000096, MGI:MGI:4417868 brush border membrane IDA 2290270 (MGI:MGI:73162, PMID:1648219) MGI MGI:MGI:73162 , PMID:1648219 cell junction ISO UniProtKB:P13688 2290270 MGI GO_REF:0000096, MGI:MGI:4834177 cell junction ISO RGD:67396 2290270 RGD GO_REF:0000096, MGI:MGI:4417868 cell projection IEA UniProtKB-KW:KW-0966 2290270 UniProtKB GO_REF:0000004, MGI:MGI:1354194 cell surface ISO UniProtKB:P13688 2290270 MGI GO_REF:0000096, MGI:MGI:4834177 cell surface IDA 2290270 (MGI:MGI:3835235, PMID:19008452) UniProtKB MGI:MGI:3835235 , PMID:19008452 cell-cell junction ISO UniProtKB:P13688 2290270 MGI GO_REF:0000096, MGI:MGI:4834177 ciliary membrane IDA 2290270 (MGI:MGI:5300833, PMID:22179047) MGI MGI:MGI:5300833 , PMID:22179047 cytoplasmic vesicle IEA UniProtKB-KW:KW-0968 2290270 UniProtKB GO_REF:0000004, MGI:MGI:1354194 external side of plasma membrane IDA 2290270 (MGI:MGI:2667426 more ... MGI MGI:MGI:2667426 more ... extracellular space IDA 2290270 (MGI:MGI:3848729, PMID:19358828) MGI MGI:MGI:3848729 , PMID:19358828 integral component of membrane ISO UniProtKB:P13688 2290270 (MGI:MGI:2179379, PMID:11994468) MGI MGI:MGI:2179379 , PMID:11994468 lateral plasma membrane ISO RGD:67396 2290270 RGD GO_REF:0000096, MGI:MGI:4417868 membrane IDA 2290270 (MGI:MGI:5608587 more ... MGI MGI:MGI:5608587 more ... plasma membrane ISO RGD:67396 2290270 RGD GO_REF:0000096, MGI:MGI:4417868 plasma membrane IDA 2290270 (MGI:MGI:5300833, PMID:22179047) MGI MGI:MGI:5300833 , PMID:22179047 plasma membrane ISO UniProtKB:P13688 2290270 MGI GO_REF:0000096, MGI:MGI:4834177 T cell receptor complex colocalizes_with ISO UniProtKB:P13688 2290270 MGI GO_REF:0000096, MGI:MGI:4834177 Molecular Function actin binding ISO UniProtKB:P13688 2290270 MGI GO_REF:0000096, MGI:MGI:4834177 bile acid transmembrane transporter activity ISO RGD:67396 2290270 RGD GO_REF:0000096, MGI:MGI:4417868 calmodulin binding ISO RGD:67396 2290270 RGD GO_REF:0000096, MGI:MGI:4417868 filamin binding ISO UniProtKB:P13688 2290270 MGI GO_REF:0000096, MGI:MGI:4834177 granulocyte colony-stimulating factor receptor binding IPI UniProtKB:P40223 2290270 (MGI:MGI:4837548, PMID:21029969) UniProtKB MGI:MGI:4837548 , PMID:21029969 identical protein binding ISO UniProtKB:P13688 2290270 MGI GO_REF:0000096, MGI:MGI:4834177 kinase binding ISO UniProtKB:P13688 2290270 MGI GO_REF:0000096, MGI:MGI:4834177 protein binding IPI UniProtKB:P29351 2290270 (MGI:MGI:1326994 more ... UniProtKB MGI:MGI:1326994 more ... protein binding IPI UniProtKB:P98083 2290270 (MGI:MGI:3057041, PMID:15467833) UniProtKB MGI:MGI:3057041 , PMID:15467833 protein binding IPI UniProtKB:Q8VIM0 2290270 (MGI:MGI:5614156, PMID:25363763) UniProtKB MGI:MGI:5614156 , PMID:25363763 protein binding IPI UniProtKB:P25911 2290270 (MGI:MGI:5478702, PMID:22496641) UniProtKB MGI:MGI:5478702 , PMID:22496641 protein binding IPI UniProtKB:P35235 2290270 (MGI:MGI:1326994, PMID:9867848) MGI MGI:MGI:1326994 , PMID:9867848 protein dimerization activity ISO RGD:67396 2290270 RGD GO_REF:0000096, MGI:MGI:4417868 protein homodimerization activity ISO UniProtKB:P13688 2290270 MGI GO_REF:0000096, MGI:MGI:4834177 protein homodimerization activity ISO RGD:67396 2290270 RGD GO_REF:0000096, MGI:MGI:4417868 protein kinase binding ISO RGD:67396 2290270 RGD GO_REF:0000096, MGI:MGI:4417868 protein phosphatase binding ISO UniProtKB:P13688 2290270 MGI GO_REF:0000096, MGI:MGI:4834177 protein tyrosine kinase binding ISO UniProtKB:P13688 2290270 MGI GO_REF:0000096, MGI:MGI:4834177 protein tyrosine kinase binding IPI UniProtKB:P48025 2290270 (MGI:MGI:5478702, PMID:22496641) UniProtKB MGI:MGI:5478702 , PMID:22496641 Toll-like receptor binding IPI UniProtKB:Q9QUK6 2290270 (MGI:MGI:5478702, PMID:22496641) UniProtKB MGI:MGI:5478702 , PMID:22496641 virion binding NOT IDA 2290270 (MGI:MGI:3053174, PMID:8380065) MGI MGI:MGI:3053174 , PMID:8380065 virion binding IDA 2290270 (MGI:MGI:3053174, PMID:8380065) MGI MGI:MGI:3053174 , PMID:8380065 virus receptor activity IDA 2290270 (MGI:MGI:49235, PMID:1719235) MGI MGI:MGI:49235 , PMID:1719235 virus receptor activity NOT IDA 2290270 (MGI:MGI:5608587, PMID:2164599) MGI MGI:MGI:5608587 , PMID:2164599
Gene-Chemical Interaction Annotations
